Evidence map›Paper›PMID 34180104›Full record

ArticleCell proliferation2021

Thymopentin alleviates premature ovarian failure in mice by activating YY2/Lin28A and inhibiting the expression of let-7 family microRNAs.

Te Liu, Fangyuan Jing, Peirong Huang, Zixiang Geng, Jianghong Xu, Jiahui Li, Danping Chen, Ying Zhu, Zhenxin Wang, Willian Huang and 1 more

Open access · goldAbstract read
In one paragraph

Article in Cell proliferation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
6.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Cell Senescence and Central Regulators of Immune Response.International journal of molecular sciences · 2022
    Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Te LiuShanghai Geriatric Institute of Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.ORCID https://orcid.org/0000-0003-3976-3489
Fangyuan JingShanghai Geriatric Institute of Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Peirong HuangDepartment of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Zixiang GengDepartment of Acupuncture, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Jianghong XuDepartment of gynaecology, Jingan Hospital of Traditional Chinese Medicine, Shanghai, China.
Jiahui LiDepartment of gynaecology, Jingan Hospital of Traditional Chinese Medicine, Shanghai, China.
Danping ChenDepartment of gynaecology, Jingan Hospital of Traditional Chinese Medicine, Shanghai, China.
Ying ZhuDepartment of gynaecology, Jingan Hospital of Traditional Chinese Medicine, Shanghai, China.
Zhenxin WangDepartment of Laboratory Medicine of Zhongshan Hospital and institute of Biomedical Science, Fudan University, Shanghai, China.
Willian HuangHainan Zhonghe Pharmaceutical Co., Ltd, Haikou, China.
Chuan ChenShanghai Geriatric Institute of Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Shanghai Traditional Chinese Medicine Hospital · CNShanghai University of Traditional Chinese Medicine · CNShanghai Jiao Tong University · CNSun Yat-sen University · CN

Funding

National Natural Science Foundation of China 81973899Three-Year Action Plan for Strengthening the Public Health System in Shanghai GWV-10.2-YQ09
6 · The paper itself

Abstract

objectiveThymopentin (5TP) significantly improved typical murine premature ovarian failure (POF) symptoms induced by a high-fat and high-sugar (HFHS) diet. However, its effect and mechanism remain unclear. MATERIALS AND

methodsRNA-Seq was used to detect the differentially expressed genes among each group. HFHS-induced POF mouse model was generated and injected with siRNA using Poly (lactic-co-glycolic acid) (PLGA) as a carrier.

resultsRNA-Seq suggested that 5TP promoted the expression of Yin Yang 2 (YY2) in mouse ovarian granulosa cell (mOGC) of HFHS-POF mice. Luciferase reporter assay indicated that 5TP promoted the binding of YY2 to the specific sequence C(C/T)AT(G/C)(G/T) on the Lin28A promoter and promoted Lin28A transcription and expression. We continuously injected PLGA-cross-linked siRNA nanoparticles targeting YY2 into HFHS-POF mice (siYY2@PLGA), which significantly reduced the therapeutic effect of 5TP. siYY2@PLGA injection also significantly attenuated the upregulation of Lin28a expression in mOGCs induced by 5TP and enhanced the expression of let-7 family microRNAs, thereby inhibiting the proliferation and division of mOGCs. qPCR results showed that there was a significant difference in the expression levels of exosome-derived Yy2 mRNAs between POF patients and normal women, and that there was a specific correlation between the expression level of exosome-derived Yy2 and the peripheral concentrations of the blood hormones pregnenolone, progesterone and oestradiol.

conclusionsThymopentin promotes the transcriptional activation of Lin28A via stimulating transcription factor YY2 expression, inhibits the activity of let-7 family microRNAs and alleviates the ageing of ovarian granulosa cells, ultimately achieving a therapeutic effect on POF in mice.

Indexed as

AnimalsBiomarkersCell ProliferationDisease Models, AnimalExosomesFemaleGene Expression RegulationHumansMiceMice, Inbred C57BLMicroRNAsPrimary Ovarian InsufficiencyPromoter Regions, GeneticRNA-Binding ProteinsRNA InterferenceRNA, Small InterferingBiomarkersLin-28 protein, mouseMicroRNAsmirnlet7 microRNA, mouseRNA-Binding ProteinsRNA, Small InterferingThymopentinTranscription FactorsYY2 protein, mouseexosomehigh-fat and high-sugar (HFHS)poly(lactic-co-glycolic acid [PLGA]) nanoparticlepremature ovarian failureYin Yang 2 (YY2)

Identifiers

PMID34180104
PMCPMC8349654
OpenAlexW3177352346

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.